Neumann Capital Management LLC Lowers Stock Position in Unum Group (NYSE:UNM)

Neumann Capital Management LLC decreased its position in Unum Group (NYSE:UNM) by 4.1% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 15,998 shares of the financial services provider’s stock after selling 685 shares during the period. Neumann Capital Management LLC’s holdings in Unum Group were worth $1,168,000 at the end of the most recent quarter.

A number of other large investors have also modified their holdings of UNM. Brighton Jones LLC purchased a new position in Unum Group during the fourth quarter worth approximately $247,000. Viking Fund Management LLC purchased a new position in shares of Unum Group during the 4th quarter valued at approximately $5,112,000. MBM Wealth Consultants LLC grew its stake in Unum Group by 3.9% in the 4th quarter. MBM Wealth Consultants LLC now owns 5,594 shares of the financial services provider’s stock valued at $408,000 after acquiring an additional 209 shares during the period. Atomi Financial Group Inc. increased its holdings in Unum Group by 20.5% in the 4th quarter. Atomi Financial Group Inc. now owns 4,525 shares of the financial services provider’s stock worth $330,000 after acquiring an additional 770 shares in the last quarter. Finally, UMB Bank n.a. raised its position in Unum Group by 8.5% during the fourth quarter. UMB Bank n.a. now owns 4,084 shares of the financial services provider’s stock worth $298,000 after acquiring an additional 319 shares during the period. Institutional investors and hedge funds own 86.57% of the company’s stock.

Insiders Place Their Bets

In other Unum Group news, EVP Timothy Gerald Arnold sold 10,000 shares of the stock in a transaction that occurred on Wednesday, November 27th. The shares were sold at an average price of $76.92, for a total value of $769,200.00. Following the sale, the executive vice president now directly owns 54,827 shares of the company’s stock, valued at approximately $4,217,292.84. This represents a 15.43 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, EVP Christopher W. Pyne sold 3,250 shares of Unum Group stock in a transaction on Wednesday, November 6th. The stock was sold at an average price of $70.02, for a total transaction of $227,565.00. Following the sale, the executive vice president now directly owns 50,762 shares of the company’s stock, valued at approximately $3,554,355.24. This trade represents a 6.02 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 107,914 shares of company stock worth $7,998,745 over the last three months. Company insiders own 0.93% of the company’s stock.

Unum Group Trading Up 0.3 %

Shares of Unum Group stock opened at $75.54 on Friday. The stock has a 50 day moving average of $73.86 and a 200 day moving average of $63.41. The company has a debt-to-equity ratio of 0.32, a quick ratio of 0.28 and a current ratio of 0.28. The firm has a market capitalization of $13.79 billion, a price-to-earnings ratio of 8.18, a PEG ratio of 1.07 and a beta of 0.81. Unum Group has a fifty-two week low of $46.39 and a fifty-two week high of $77.63.

Unum Group (NYSE:UNM) last announced its earnings results on Tuesday, October 29th. The financial services provider reported $2.13 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.10 by $0.03. Unum Group had a return on equity of 15.21% and a net margin of 13.76%. The company had revenue of $3.22 billion for the quarter, compared to analyst estimates of $3.26 billion. During the same quarter in the previous year, the company earned $1.94 earnings per share. The firm’s quarterly revenue was up 4.0% compared to the same quarter last year. As a group, research analysts predict that Unum Group will post 8.54 earnings per share for the current year.

Unum Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Friday, January 24th will be paid a dividend of $0.42 per share. The ex-dividend date is Friday, January 24th. This represents a $1.68 dividend on an annualized basis and a yield of 2.22%. Unum Group’s dividend payout ratio (DPR) is presently 18.18%.

Analysts Set New Price Targets

A number of research firms have recently commented on UNM. Bank of America boosted their target price on shares of Unum Group from $54.00 to $63.00 and gave the stock a “neutral” rating in a research note on Thursday, October 10th. Piper Sandler increased their target price on Unum Group from $74.00 to $82.00 and gave the company an “overweight” rating in a report on Wednesday, December 18th. Truist Financial raised their target price on Unum Group from $70.00 to $75.00 and gave the company a “buy” rating in a research report on Friday, November 1st. BMO Capital Markets started coverage on Unum Group in a research report on Thursday. They set an “outperform” rating and a $91.00 price target for the company. Finally, Evercore ISI upgraded Unum Group from an “in-line” rating to an “outperform” rating and raised their price objective for the company from $67.00 to $84.00 in a report on Thursday, November 14th. Five analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $76.75.

Unum Group Profile

Unum Group, together with its subsidiaries, provides financial protection benefit solutions primarily in the United States, the United Kingdom, Poland, and internationally. It operates through Unum US, Unum International, Colonial Life, and Closed Block segment. The company offers group long-term and short-term disability, group life, and accidental death and dismemberment products; supplemental and voluntary products, such as individual disability, voluntary benefits, and dental and vision products; and accident, sickness, disability, life, and cancer and critical illness products.